About Wacker Chemie
Wacker Chemie is a company based in Munchen (Germany) founded in 1914. The company has 16,640 employees as of December 31, 2024. Wacker Chemie has completed 2 acquisitions, including ADL Biopharma and Scil Proteins. Wacker Chemie offers products and services including Silicones, Dispersions, and Biotech Services. Wacker Chemie operates in a competitive market with competitors including AMILI, Enduro, BioCina, Eleszto Genetika and Shenzhen Qianhai Xiaozao Technology, among others.
- Headquarter Munchen, Germany
- Employees 16640 as on 31 Dec, 2024
- Stage Public
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Wacker Chemie Ag
-
Annual Revenue
$6.45 B (USD)-4.14as on Dec 31, 2025
-
Net Profit
-$940 M (USD)-431.95as on Dec 31, 2025
-
EBITDA
$731.49 M (USD)-11.9as on Dec 31, 2024
-
Latest Funding Round
$67.07 M (USD), Grant
Nov 27, 2020
- Investors
-
Employee Count
16640
as on Dec 31, 2024
-
Investments & Acquisitions
ADL Biopharma
& 1 more
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Wacker Chemie
Wacker Chemie is a publicly listed company on the XETR with ticker symbol WCH in Germany, operating in the Process industries sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Wacker Chemie
Wacker Chemie offers a comprehensive portfolio of products and services, including Silicones, Dispersions, and Biotech Services.
Materials for e-mobility and composites applications
Solutions for industrial coatings and adhesives
Production of plasmid DNA and mRNA therapeutics
People of Wacker Chemie
Unlock access to complete
Unlock access to complete
Funding Insights of Wacker Chemie
Investors in Wacker Chemie
Wacker Chemie has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include European Union.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
|
Locked | Locked | Locked |
Investor details for Wacker Chemie
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Wacker Chemie
Wacker Chemie has strategically engaged in corporate development activities, having acquired 2 companies. Notable acquisitions include ADL Biopharma and Scil Proteins.
Investment portfolio details for Wacker Chemie
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
APIs and intermediates are developed and manufactured for pharmaceuticals.
|
Locked | Locked | 2014 | Locked | |
|
Unique Affilin-based proteins are generated and optimized for therapeutic applications.
|
Locked | Locked | 1999 | Locked |
Complete acquisition details for Wacker Chemie
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Wacker Chemie
Detailed financials for Wacker Chemie
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Wacker Chemie Comparisons
Peer comparison for Wacker Chemie
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Wacker Chemie
Wacker Chemie operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as AMILI, Enduro, BioCina, Eleszto Genetika and Shenzhen Qianhai Xiaozao Technology, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Gut microbiome insights, analytics, tests, and therapeutics are provided.
|
|
| Locked | Locked | Locked |
Microbial strains are manufactured by Enduro as a CDMO.
|
|
| Locked | Locked | Locked |
CDMO offering microbial expression systems-based biologics development and manufacturing services
|
|
| Locked | Locked | Locked |
CDMO offers microbial expression systems-based biologics development
|
|
| Locked | Locked | Locked |
Offers microbial expression systems-based biologics development and manufacturing services
|
Detailed competitors of Wacker Chemie
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Wacker Chemie
Complete news archive for Wacker Chemie
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Wacker Chemie
Wacker Chemie was founded in 1914 and raised its 1st funding round 106 years after it was founded.
Wacker Chemie is headquartered in Munchen, Germany. It is registered at Munchen, Bayern, Germany.
As of Dec 31, 2024, the latest employee count at Wacker Chemie is 16,640.
Annual revenue of Wacker Chemie is $6.45B as on Dec 31, 2025.
Wacker Chemie was founded in 1914 in Munich, Germany, and operates in the chemicals sector. Silicones, polymers, and bio-solutions are produced for applications across multiple industries. A 3D printing process for gum and candies has been developed, utilizing CANDY2GUM technology to enable confectionery production with altered mouthfeel. In 2022, revenues of 8.63 billion and net profit of 1.31 billion were reported.
Wacker Chemie offers Silicones, Dispersions, and Biotech Services.
Yes, Wacker Chemie is publicly traded on XETR under the ticker symbol WCH.
Wacker Chemie has made 2 acquisitions, including ADL Biopharma, and Scil Proteins.
Wacker Chemie has 1 investor. Key investors include European Union.
The ticker symbol of Wacker Chemie is WCH on XETR.